Cardinal Health rises on extended CVS distribution deal…
…
Cardinal Health (CAH) closed at $220.22 in the latest trading session, marking a -1.08% move from the prior day.…
CAHs specialty-led growth, stronger EPS outlook and improving estimate momentum set up a compelling case against MCK.…
CVS Health and Cardinal Health are benefiting from healthcare growth, but differences in performance, valuation and targets shape the outlook.…
Cardinal Health (NYSE:CAH) CEO Jason Hollar said the company’s fiscal 2026 performance was supported by double-digit earnings growth across each…
Cardinal Health expects IRA pricing changes to pressure Pharma revenues while protecting profitability through compensation and durable distribution agreements.…
Cardinal Healths 29% rally reflects stronger specialty growth, MSO expansion and higher-margin assets, but cost pressures could test the uptrend.…
In the latest trading session, Cardinal Health (CAH) closed at $240.49, marking a -2.71% move from the previous day.…
Cardinal Healths generic volumes, profitable brand-to-generic conversions and Red Oak program continue to support Pharma profits.…
…
Cardinal Health (CAH) gave investors plenty to like in its fiscal fourth-quarter report this week, sending shares to a record…
The quarter wasnt totally clean, but strong profitability matters the most.…
Cardinal Health heads into Q4 earnings with pharma, specialty and higher-margin businesses in focus as investors watch if growth offsets…
Cardinal Health (CAH) closed the most recent trading day at $235.6, moving +2.42% from the previous trading session.…
CVS, CAH, HUM and ACAD show favorable earnings indicators ahead of Q2 results as healthcare demand stays resilient despite margin…
Cardinal Health (CAH) reached $225.75 at the closing of the latest trading day, reflecting a -1.21% change compared to its…
…
[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Gauze…
Cardinal Health (CAH) closed at $237.92 in the latest trading session, marking a +1.35% move from the prior day.…
In the latest trading session, Cardinal Health (CAH) closed at $233.01, marking a +1.79% move from the previous day.…
Ein massiver Volumensprung signalisiert den Einstieg institutioneller Investoren nach starken Quartalszahlen. Die strategische Expansion in margenstarke Spezialbereiche wie die…
Cardinal Health is back in focus as fresh Street research reshapes the price target conversation, with several firms trimming their…
Whether youre a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top…
Cardinal Healths specialty growth, strong cash flow and expanding higher-margin businesses are boosting earnings momentum despite IRA and GMPD risks.…
Cardinal Health is expanding beyond drug distribution into specialty care, logistics and nuclear medicine, deepening its role in US healthcare…
…
We wish we hadnt initiated the stock ahead of the quarter, in early March, but hindsight is 20/20.…
Drug distributor Cardinal Health on Thursday raised its 2026 profit forecast range, betting on strong demand for costly specialty medicines…
Cardinal Health beats profit forecast, raises outlook…
CAHs Q3 results are likely to benefit from strong specialty momentum and GMPD progress, but tougher comps and tariff pressures…
In the closing of the recent trading day, Cardinal Health (CAH) stood at $200.55, denoting a -2.13% move from the…
Cardinal Health (CAH) reached $204.92 at the closing of the latest trading day, reflecting a -2.96% change compared to its…
In the latest trading session, Cardinal Health (CAH) closed at $211.83, marking a -1.45% move from the previous day.…
CAH expands Ac-225 capacity, boosting its role in radiopharma as rising clinical demand and future cancer therapy commercialization drive growth.…
In the latest trading session, Cardinal Health (CAH) closed at $211.31, marking a +2.42% move from the previous day.…
Cardinal Health (CAH) closed at $207.7 in the latest trading session, marking a -1.71% move from the prior day.…
CAHs turnaround gains traction with strong earnings growth and margin expansion, outpacing MCKs steady performance outlook.…
Cardinal Health (CAH) concluded the recent trading session at $207.83, signifying a -1.47% move from its prior days close.…
CAHs $1.8 billion free cash flow fuels buybacks, dividends, and reinvestment, as Cardinal Health eyes disciplined capital deployment and targeted…
In the most recent trading session, Cardinal Health (CAH) closed at $211.87, indicating a -2.08% shift from the previous trading…
Image source: The Motley Fool.DATETuesday, March 3, 2026 at 5 p.m. ETCALL PARTICIPANTSChief Executive Officer — Jerrell SheltonChief Financial Officer…
Boot Barn, Brinker International, Tapestry and Cardinal Health have been highlighted in this Screen of The Week article.…
Cardinal Health (CAH) agiert als die fundamentale Infrastruktur des US-Gesundheitswesens, transformiert sich jedoch aggressiv vom reinen Kistenschieber zum hochmargigen Spezialisten.…
Cardinal Health on Thursday raised its expectations for annual profit after surpassing Wall Street estimates for quarterly results, as it…
Cardinal Healths second-quarter earnings might have been driven by Pharma and Specialty Solutions, as strong utilization and GLP-1 momentum must…
Cardinal (CAH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report.…
Cardinal Health (CAH) reached $210.93 at the closing of the latest trading day, reflecting a +1.25% change compared to its…
In the latest trading session, Cardinal Health (CAH) closed at $208.26, marking a +2.83% move from the previous day.…
These are some of the stocks posting the largest midday moves.…